Answers are grounded in this paper and cite their sources.
Background Randomized controlled trials suggest that Chinese patent medicines may improve radiation-induced oral mucositis and reduce adverse events; however, their efficacy and safety have not been systematically synthesized. Objective To evaluate the clinical efficacy and safety of Chinese patent medicines for radiation-induced oral mucositis. Methods Seven databases (China National Knowledge Infrastructure, Wanfang, VIP, PubMed, Embase, Web of Science, and the Cochrane Library) were searched from inception to March 2025. Risk of bias was assessed using the Cochrane Risk of Bias 2.0 tool. A network meta-analysis was conducted, and the surface under the cumulative ranking curve was used to rank interventions. Results Nine randomized controlled trials involving 919 patients and 11 interventions were included. Heat-Clearing Throat-Soothing Formula ranked highest for overall clinical efficacy (SUCRA = 81.8%), whereas the Lonicera-Lilium Tablets ranked lowest (12.1%). Throat-Clearing Oral Liquid showed the greatest probability of pain relief (77.8%), compared with minimal effects in the control group (0.8%). Heat-Clearing Throat-Soothing Formula was most effective in reducing severe (grade three to four) oral mucositis (86.6%), while the control group ranked lowest (0.4%). Conclusion Chinese patent medicines appear more effective than control interventions for radiation-induced oral mucositis. Lonicera-Lilium Tablets, Throat-Clearing Oral Liquid, and Heat-Clearing Throat-Soothing Formula showed the most favorable profiles across outcomes. However, given limited evidence, larger high-quality randomized controlled trials are required to confirm these findings.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: